[1] Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology,2009, 49:1017-1044.
[2] Mani H, Kleiner DE. Liver biopsy findings in chronic hepatitis B. Hepatology, 2009,49:61-71.
[3] Enomoto M, Morikawa H, Tamori A, et al. Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B. World J Gastroenterol,2014, 20:12031-12038.
[4] Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology,2003,38:518-526.
[5] Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology,2007,46:32-36.
[6] Zeng MD, Lu LG, Mao YM, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology,2005,42:1437-1445.
[7] Poynard T, Imbert-Bismut F, Munteanu M, et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol,2004,3:8.
[8] Zhou K, Gao CF, Zhao YP, et al. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol,2010, 25:1569-1577.
[9] Xu XY, Kong H, Song RX, et al. The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: a systematic review and meta-analysis of diagnostic test accuracy. PLoS One,9:e100182.
[10] Cheng J, Hou J, Ding H, et al. Validation of ten noninvasive diagnostic models for prediction of liver fibrosis in patients with chronic hepatitis B. PLoS One,2015,10:e0144425.
[11] Ma J, Jiang Y, Gong G. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection. European Journal of Gastroenterology & Hepatology,2013,25:428-434.
[12] Lin ZH, Xin YN, Dong QJ, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology,2011,53:726-736.
[13] Li Y, Chen Y, Zhao Y. The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis. PLoS One,2014,9:e105728.
[14] Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology,2015,61:292-302.
[15] Castera L. Hepatitis B: are non-invasive markers of liver fibrosis reliable Liver Int,2014,34:91-96.
[16] Liu XD, Wu JL, Liang J, et al. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients. World J Gastroenterol,2012, 18:2784-2792.
[17] Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol,2003,29: 1705-1713.
[18] Friedrich-Rust M, Ong MF, Martens S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology,2008, 134: 960-974.
[19] Bardou-Jacquet E, Legros L, Soro D, et al. Effect of alcohol consumption on liver stiffness measured by transient elastography. World J Gastroenterol,2013, 19:516-522.
[20] Chon YE, Choi EH, Song KJ, et al. Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis. PLoS One,2012,7:e44930.
[21] Gaia S, Carenzi S, Barilli AL, et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol,2011,54:64-71.
[22] Fraquelli M, Rigamonti C, Casazza G, et al. Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J Hepatol,2011,54:621-628.
[23] 夏长虹,王文欢,王伟芳,等. Fibrotouch与Fibroscan检测肝脏硬度的临床效能比较. 北京医学,2014,36:202-205.
[24] 吴娜,张明媛,吴瑞红,等. FibroScan与FibroTouch对肝纤维化程度诊断价值的比较分析. 临床肝胆病杂志,30:624-627.
[25] 魏玉统,贾胜男,刘苗苗,等. FibroTouch 检测脾硬度与肝硬化患者食管胃底静脉曲张程度的相关性探讨. 临床肝胆病杂志,2015,31:374-377.
[26] Zeng X, Xu C, He D, et al. Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B. Croat Med J,2015,56:272-279.
[27] 曲加祥. FibroScan与多参数模型联合诊断肝纤维化、肝硬化. 山西:山西医科大学,2012:1-25.
[28] Friedrich-Rust M, Wunder K, Kriener S, et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology,2009,252:595-604.
[29] Takahashi H, Ono N, Eguchi Y, et al. Evaluation of acoustic radiation force impulse elastography fibrosis staging of chronic liver disease: a pilot study. Liver Int,2010,30:538-545.
[30] Bota S, Herkner H, Sporea I, et al. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int,2013,33: 1138-1147.
[31] Friedrich-Rust M, Nierhoff J, Lupsor M, et al. Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat,2012,19:212-219.
[32] Yoneda M, Suzuki K, Kato S, et al. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology,2010,256:640-647.
[33] Gong X, Xu Q, Xu Z, et al. Real-time elastography for the differentiation of benign and malignant breast lesions: a meta-analysis. Breast Cancer Res Treat,2011, 130:11-18.
[34] Tatsumi C, Kudo M, Ueshima K, et al. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography. Intervirology,2008,51:27-33.
[35] Kobayashi K, Nakao H, Nishiyama T, et al. Diagnostic accuracy of real-time tissue elastography for the staging of liver fibrosis: a meta-analysis. Eur Radiol,2015, 25:230-238.
[36] Talwalkar JA, Yin M, Fidler JL, et al. Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology,2008,47:332-342. |
